Clinical Researcher—April 2021 (Volume 35, Issue 3) PEER REVIEWED Holly Bookless, BSN, RN, NE-BC; Paula Smailes, DNP, RN, CCRP; Todd Lusch, BA; Deanna Golden-Kreutz, PhD What was originally known as the extramural General Clinical Research Center (GCRC) program was funded from the 1960s, first by the National Center for Research Resources within the National […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) PEER REVIEWED Christina Morris; Erika Stevens, MA Biotechnology, medical device, and pharmaceutical companies are seeking other industries’ disruptive digital technologies to aid in improving operational efficiencies and resourcing. For example, customer-centric robotic process automation (RPA) is thriving as an approach to handling routine financial processes in information […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) OPINION Allison Kalloo, MPH Newsflash: Minorities—African Americans in particular—over-index in measures of poor health outcomes. By now, you already know that combating a deadly plague has only been exacerbated by persistent disparities in disease prevalence and by the stark and longstanding underrepresentation of communities of color in […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) GOOD MANAGEMENT PRACTICE Scott Gray It's no secret that patient diversity is a major issue in clinical trials, and that a lack of diversity makes it difficult to measure efficacy and safety. However, even given the U.S. Food and Drug Administration’s recent guidance, there is not […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) SITES & SPONSORS Mark Clements, MD, PhD, CPI, FAAP; Komathi Stem, MS COVID-19’s effect on clinical trials is a tale of two outcomes. Near-term, the pandemic has been devastatingly disruptive. About 80% of non-COVID-19 trials were either stopped or interrupted.{1} As of January 2021, COVID-19 had stopped […]
